2709
Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period) received placebo, RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined.
 Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period): Subject; Women: Subject.Gender; aged < or = 75 yr; > or = 2 yr: Subject.Age; RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined: Treatment; 60 mg/d: Treatment.Dosage; 10 mg/d: Treatment.Dosage; 60 mg/d: Treatment.Dosage; 10 mg/d: Treatment.Dosage; RLX: Treatment.Drug; ALN: Treatment.Drug; RLX: Treatment.Drug; ALN: Treatment.Drug; ALN: Combination.Drug; RLX: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period): Subject; Women: Subject.Gender; aged < or = 75 yr; > or = 2 yr: Subject.Age; RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined: Treatment; 60 mg/d: Treatment.Dosage; 10 mg/d: Treatment.Dosage; 60 mg/d: Treatment.Dosage; 10 mg/d: Treatment.Dosage; RLX: Treatment.Drug; ALN: Treatment.Drug; RLX: Treatment.Drug; ALN: Treatment.Drug; ALN: Combination.Drug; RLX: Combination.Drug